Artivion has finalized its acquisition of Endospan Ltd., adding the FDA-approved NEXUS Aortic Arch System to its portfolio of ...
Medical Device Network on MSN
Artivion strengthens aortic arch portfolio with $135m Endospan acquisition
As per a 2019 deal, Artivion secured the rights to purchase Endospan upon the latter’s US approval of Nexus, a treatment for ...
Artivion, Inc. announced that it has completed the acquisition of its long-standing partner Endospan Ltd. On May 8, Artivion announ ...
Endospan, headquartered in Israel, specializes in endovascular technologies designed to treat complex aortic arch disease.
Total Aortic Arch Replacement is a surgical procedure that involves replacing the entire aortic arch, which is the curved portion of the aorta that extends from the heart. This procedure is typically ...
Endospan, a pioneer in endovascular solutions for complex aortic pathologies, today announced that Artivion, Inc. (NYSE: AORT) has closed the transaction to acquire the company. This strategic ...
FDA approval was supported by the one-year results of the TRIOMPHE Investigational Device Exemption (IDE) Study evaluating the NEXUS® System shown to effectively treat aortic arch disease, including ...
A beveled aortic hemiarch replacement is a surgical procedure to repair an aortic aneurysm or aortic dissection in the ascending aorta and arch of the aorta. This procedure involves removing the ...
(NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today announced that it has completed the acquisition of its long-standing partner Endospan Ltd. ("Endospan"), a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results